Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013

Eurosurveillance

Volumn 19, Issue 7, 2014, Pages

  Shulman, L M ^a,b   Gavrilin, E ^c   Jorba, J ^d   Martin, J ^e   Burns, C C ^d   Manor, Y ^a   Moran Gilad, J ^f,g   Sofer, D ^a   Hindiyeh, M Y ^a   Gamzu, R ^b,f   Mendelson, E ^a,b   Grotto, I ^f,h  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^f MINISTRY OF HEALTH   (Israel)

^g Clinical Institute of Infectious Diseases and Immunology   (Spain)

^h BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP1;

ANIMAL CELL; ARTICLE; FECES ANALYSIS; GENE SEQUENCE; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; POLIOMYELITIS; POLIOMYELITIS VIRUS; REAL TIME POLYMERASE CHAIN REACTION; SEWAGE; VIRUS CULTURE; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 84894250920     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.7.20709     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention (CDC). Evaluating surveillance indicators supporting the Global Polio Eradication Initiative, 2011-2012. MMWR Morb Mortal Wkly Rep. 2013;62(14):270-4.
2. Kew OM, Mulders MN, Lipskaya GY, de Silva E, Pallansch MA. Molecular epidemiology of polioviruses. Seminars in Virology. 1995;6:401-5. http://dx.doi.org/10.1016/S1044-5773(05)80017-4
3. Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine - live. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia, PA: Saunders/Elsevier; 2008. p. 631-85.
4. Shulman LM. Polio and its epidemiology. In: Meyers RA, editor. Encyclopedia of sustainability science and technology. SpringerLink (Online service). New York, NY: Springer; 2012. p. 8123-73. http://dx.doi.org/10.1007/978-1-4419-0851-3_839
5. Shulman LM, Manor Y, Sofer D, Mendelson E. Bioterrorism and surveillance for infectious diseases - lessons from poliovirus and enteric virus surveillance. J Bioterr Biodef. 2012;S4.
6. World Health Organization (WHO) Regional Office for Europe. Certification of poliomyelitis eradication. Fifteenth meeting of the European Regional Certification Commission, Copenhagen, 19-21 June 2002. Copenhagen: WHO Regional Office for Europe; 2005. Available from: http://www.euro.who.int/_data/assets/pdf_file/0003/79374/E88105.pdf
7. World Health Organization Country Office Tajikistan; WHO Regional Office for Europe; European Centre for Disease Prevention and Control. Outbreak of poliomyelitis in Tajikistan in 2010: risk for importation and impact on polio surveillance in Europe? Euro Surveill. 2010;15(17):pii=19558.
8. Slater PE, Orenstein WA, Morag A, Avni A, Handsher R, Green MS, et al. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet. 1990;335(8699):1192-5; discussion 1196-8. http://dx.doi.org/10.1016/0140-6736(90)92705-M
9. Shulman LM, Handsher R, Yang CF, Yang SJ, Manor J, Vonsover A, et al. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol. 2000;38(3):945-52.
10. Manor Y, Handsher R, Halmut T, Neuman M, Bobrov A, Rudich H, et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J Clin Microbiol. 1999;37(6):1670-5.
11. Swartz TA, Handsher R, Manor Y, Stoeckel P, Barkay A, Mendelson E, et al. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis. Vaccine. 1998;16(20):2090-5. http://dx.doi.org/10.1016/S0264-410X(98)00071-1
12. World Health Organization (WHO). WHO-recommended surveillance standard of poliomyelitis. Geneva: WHO. [Accessed 01-02-2014]. Available from: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/poliomyelitis_standards/en/
13. Manor Y, Blomqvist S, Sofer D, Alfandari J, Halmut T, Abramovitz B, et al. Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Appl Environ Microbiol. 2007;73(18):5954-8. http://dx.doi.org/10.1128/AEM.02537-06
14. Manor Y, Handsher R, Halmut T, Neuman M, Abramovitz B, Mates A, et al. A double-selective tissue culture system for isolation of wild-type poliovirus from sewage applied in a long-term environmental surveillance. Appl Environ Microbiol. 1999;65(4):1794-7.
15. Anis E, Kopel E, Singer SR, Kaliner E, Moerman L, Moran-Gilad J, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill. 2013;18(38):pii=20586.
16. Manor Y, Shulman LM, Kaliner E, Hindiyeh M, Ram D, Sofer D, Moran-Gilad J, Lev B, Grotto I, Gamzu R, Mendelson E. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013. Euro Surveill. 2014;19(7):pii=20708.
17. Hindiyeh MY, Moran-Gilad J, Manor Y, Ram D, Shulman LM, Sofer D, Mendelson E. Development and validation of a real time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay for investigation of wild poliovirus type 1-South Asian (SOAS)strain reintroduced into Israel, 2013 to 2014. Euro Surveill. 2014;19(7):pii=20710.
18. Hovi T, Shulman LM, van der Avoort H, Deshpande J, Roivainen M, de Gourville EM. Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect. 2012;140(1):1-13. http://dx.doi.org/10.1017/S095026881000316X
19. World Health Organization (WHO). Polio laboratory mannual. 4th ed. Geneva: WHO; 2004. WHO/IVB/04.10. Available from: http://whqlibdoc.who.int/hq/2004/WHO_IVB_04.10.pdf
20. Nakano JH, Hatch MH, Thieme ML, Nottay B. Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog Med Virol. 1978;24:178-206.
21. Kilpatrick DR, Iber JC, Chen Q, Ching K, Yang SJ, De L, et al. Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods. 2011;174(1-2):128-30.http://dx.doi.org/10.1016/j.jviromet.2011.03.020
22. Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003;77(15):8366-77. http://dx.doi.org/10.1128/JVI.77.15.8366-8377.2003
23. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389-402. http://dx.doi.org/10.1093/nar/25.17.3389
24. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4(4):406-25.
25. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731-9. http://dx.doi.org/10.1093/molbev/msr121
26. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol. 1993;10(3):512-26.
27. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29(8):1969-73. http://dx.doi.org/10.1093/molbev/mss075
28. Posada D, Crandall KA. MODELTEST: testing the model of DNA substitution. Bioinformatics. 1998;14(9):817-8. http://dx.doi.org/10.1093/bioinformatics/14.9.817
29. Jorba J, Campagnoli R, De L, Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol. 2008;82(9):4429-40. http://dx.doi.org/10.1128/JVI.02354-07
30. Rambaut A, Suchard M, Xie D, Drummond A. Tracer v1.5. 2013. [Accessed 1 Jun 2013]. Available from: http://beast.bio.ed.ac.uk/Tracer
31. Rambaut A, Drummond A. FigTree V1.4. [Accessed 1 Jun 2013]. Available from: http://tree.bio.ed.ac.uk/software/figtree
32. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123(3):585-95.
33. Domingo E, Martínez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortín J, et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene. 1985;40(1):1-8. http://dx.doi.org/10.1016/0378-1119(85)90017-4
34. World Health Organization (WHO). Polio in the Syrian Arab Republic - update. Geneva: WHO; 11 November 2013. Available from: http://www.who.int/csr/don/2013_11_11polio/en/index.html
35. Centers for Disease Control and Prevention (CDC). Progress toward poliomyelitis eradication - Pakistan, January 2012-September 2013. MMWR Morb Mortal Wkly Rep. 2013;62(46):934-8.
36. World Health Organization (WHO). WHO global action plan for laboratory containment of wild polioviruses. 2nd ed. Geneva: WHO; 2003. WHO/V&B/03.11 2004. Available from: http://whqlibdoc.who.int/hq/2003/WHO_V&B_03.11.pdf?ua=1
37. World Health Organization (WHO). Global eradication of poliomyelitis by the year 2000. Resolution of the 41st World Health Assembly. Geneva: WHO: 1988. Available from: http://www.polioeradication.org/content/publications/19880513_resolution.pdf